Journal profile · Immunology
JOURNAL OF IMMUNOLOGY
ISSN 0022-1767 · eISSN 1550-6606 · American Association of Immunologists · UNITED STATES · Semimonthly · Founded 1950
JOURNAL OF IMMUNOLOGY: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.89; hybrid open access; APC about USD 3,500; median 186 days to acceptance (109 articles, last 24 months); community-reported acceptance: about 25%; 3,220 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JOURNAL OF IMMUNOLOGY is published by American Association of Immunologists and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 46% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The JI publishes peer-reviewed manuscripts describing novel findings in all areas of experimental immunology, including both basic and clinical studies.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology17.9%
- T-cell and B-cell ImmunologyImmunology and Microbiology15.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology12.6%
- Monoclonal and Polyclonal Antibodies ResearchMedicine8%
- Immune Response and InflammationImmunology and Microbiology7.5%
- CAR-T cell therapy researchMedicine3.1%
- Cell Adhesion Molecules ResearchMedicine2.8%
- Immune cells in cancerImmunology and Microbiology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.89LetPub ·
- Impact factor (publisher) 2025
- 4.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.5Publisher website ·
- CiteScore 2026-06
- 6.5LetPub ·
- CiteScore (publisher) 2025
- 15.7Publisher website ·
- SJR 2026-06
- 1.44LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 345LetPub ·
- h-index
- 535OpenAlex ·
- i10-index
- 62,197OpenAlex ·
- 2-year mean citedness
- 0.61OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 12.25%LetPub ·
Volume
- Articles per year
- 375LetPub ·
Articles by year OpenAlex count · 107,657 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 2,194 | 1,332 | 118 |
| 2025 | 3,220 | 3,056 | 1,361 |
| 2024 | 1,221 | 304 | 2,575 |
| 2023 | 2,336 | 2,226 | 5,350 |
| 2022 | 1,902 | 366 | 7,747 |
| 2021 | 1,725 | 358 | 12,977 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
186 daysMedian, submission to acceptance · P25–P75 124 days – 280 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 109 articles with submission and acceptance dates (777 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,500 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access funding may be available
Authors interested in publishing in the AAI journals may be able to publish their paper Open Access using funds available through their institution's agreement with OUP. Find out if your institution is participating
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- American Association of Immunologists
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1950
- ISSN
- 0022-1767
- Electronic ISSN
- 1550-6606
- Latest issue on the website
- Volume 215, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JOURNAL OF IMMUNOLOGY
What CAS zone is JOURNAL OF IMMUNOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, JOURNAL OF IMMUNOLOGY is in Zone 3 of Medicine, and in Zone 3 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JOURNAL OF IMMUNOLOGY?
The latest impact factor listed by LetPub is 3.89; CiteScore 6.5, h-index 535.
How long does peer review take at JOURNAL OF IMMUNOLOGY?
Based on the dates recorded on 109 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 186 days (interquartile range 124–280 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index JOURNAL OF IMMUNOLOGY?
According to LetPub and DOAJ records, JOURNAL OF IMMUNOLOGY is indexed in SCIE and Scopus.
Is JOURNAL OF IMMUNOLOGY open access, and what is the APC?
JOURNAL OF IMMUNOLOGY is a hybrid journal. For open-access publication: APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .